BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8959869)

  • 21. Prolonged function of extracorporeal hDAF transgenic pig livers perfused with human blood.
    Rees MA; Butler AJ; Chavez-Cartaya G; Wight DG; Casey ND; Alexander G; Khuder SA; White DJ; Friend PJ
    Transplantation; 2002 Apr; 73(8):1194-202. PubMed ID: 11981409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors.
    Zaidi A; Schmoeckel M; Bhatti F; Waterworth P; Tolan M; Cozzi E; Chavez G; Langford G; Thiru S; Wallwork J; White D; Friend P
    Transplantation; 1998 Jun; 65(12):1584-90. PubMed ID: 9665074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunopathology of an hDAF transgenic pig model liver xenotransplant into a primate.
    Sanchez A; Ramirez P; Pino G; Chavez R; Majado M; Munitiz V; Muñoz A; Palenciano CG; Yelamos J; Rodriguez-Gago M; Pons JA; Parrilla P
    Transplant Proc; 2003 Aug; 35(5):2041-2. PubMed ID: 12962888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production and characterization of a pig line transgenic for human membrane cofactor protein.
    Zhou CY; McInnes E; Parsons N; Langford G; Lancaster R; Richards A; Pino-Chavez G; Dos Santos Cruz G; Copeman L; Carrington C; Thompson S
    Xenotransplantation; 2002 May; 9(3):183-90. PubMed ID: 11983016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining the hDAF transgene with the GP IIb/IIIa inhibitor tirofiban improves heart performance and reduces myocardial damage following hyperacute rejection in an ex vivo perfusion model.
    Brandl U; Erhardt M; Joeckle H; Michel S; Brenner P; Bittmann I; Roessle M; Mordstein V; Hammer C; Schmoeckel M; Reichart B
    Transplant Proc; 2005; 37(1):491-2. PubMed ID: 15808686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement regulatory proteins on human and porcine nontransgenic and hDAF transgenic islet cells: expression and role in susceptibility to lysis by human serum.
    Bennet W; Sundberg B; Elgue G; Brendel M; Richards A; White DJ; Groth C; Korsgren O
    Transplant Proc; 2000 Aug; 32(5):1066. PubMed ID: 10936358
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanisms of injury in porcine livers perfused with blood of patients with fulminant hepatic failure.
    Collins BH; Chari RS; Magee JC; Harland RC; Lindman BJ; Logan JS; Bollinger RR; Meyers WC; Platt JL
    Transplantation; 1994 Dec; 58(11):1162-71. PubMed ID: 7992356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of baseline expression of human decay accelerating factor transgene on graft survival and acute humoral xenograft rejection.
    Sun H; Chen G; Liu W; Kubelik D; Yang H; White DJ; Zhong R; Garcia B
    Transplantation; 2005 Nov; 80(9):1331-9. PubMed ID: 16314803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transgenic pigs expressing human CD59, in combination with human membrane cofactor protein and human decay-accelerating factor.
    Zhou CY; McInnes E; Copeman L; Langford G; Parsons N; Lancaster R; Richards A; Carrington C; Thompson S
    Xenotransplantation; 2005 Mar; 12(2):142-8. PubMed ID: 15693845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transgenic expression in pig hearts of both human decay-accelerating factor and human membrane cofactor protein does not provide an additional benefit to that of human decay-accelerating factor alone in pig-to-baboon xenotransplantation.
    Mañez R; Lopez-Pelaez E; Centeno A; Herrera JM; Juffe A; Domenech N; Harrison R; Schuurman HJ
    Transplantation; 2004 Sep; 78(6):930-3. PubMed ID: 15385816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple genetically modified GTKO/hCD46/HLA-E/hβ2-mg porcine hearts are protected from complement activation and natural killer cell infiltration during ex vivo perfusion with human blood.
    Abicht JM; Sfriso R; Reichart B; Längin M; Gahle K; Puga Yung GL; Seebach JD; Rieben R; Ayares D; Wolf E; Klymiuk N; Baehr A; Kind A; Mayr T; Bauer A
    Xenotransplantation; 2018 Sep; 25(5):e12390. PubMed ID: 29536572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of decay-accelerating factor expression and alpha1,3-galactosyltransferase knockout affords added protection from human complement-mediated injury.
    van Denderen BJ; Salvaris E; Romanella M; Aminian A; Katerelos M; Tange MJ; Pearse MJ; d'Apice AJ
    Transplantation; 1997 Sep; 64(6):882-8. PubMed ID: 9326415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pig kidney transplantation in baboons: anti-Gal(alpha)1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation.
    Bühler L; Yamada K; Kitamura H; Alwayn IP; Basker M; Appel JZ; Colvin RB; White-Scharf ME; Sachs DH; Robson SC; Awwad M; Cooper DK
    Transplantation; 2001 Dec; 72(11):1743-52. PubMed ID: 11740383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transgenic pigs expressing human decay-accelerating factor regulated by porcine MCP gene promoter.
    Murakami H; Nagashima H; Takahagi Y; Miyagawa S; Fujimura T; Toyomura K; Nakai R; Yamada M; Kurihara T; Shigehisa T; Okabe M; Seya T; Shirakura R; Kinoshita T
    Mol Reprod Dev; 2002 Mar; 61(3):302-11. PubMed ID: 11835575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classical pathway complement destruction is not responsible for the loss of human erythrocytes during porcine liver perfusion.
    Rees MA; Butler AJ; Negus MC; Davies HF; Friend PJ
    Transplantation; 2004 May; 77(9):1416-23. PubMed ID: 15167601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of functional decay-accelerating factor (CD55) in transgenic mice protects against human complement-mediated attack.
    van Denderen BJ; Pearse MJ; Katerelos M; Nottle MB; Du ZT; Aminian A; Adam WR; Shenoy-Scaria A; Lublin DM; Shinkel TA; d'Apice AJ
    Transplantation; 1996 Feb; 61(4):582-8. PubMed ID: 8610385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The serum level of xenoantibodies, and hDAF or alphaGAL expression on pig cells, modulate in vitro the protection given by hDAF to primate complement-mediated damage.
    Díaz TM; Mañez R; Moscoso I; López D; Santamarina I; Lopez E; Centeno A; Domenéch N
    Transplant Proc; 2005; 37(1):510-1. PubMed ID: 15808692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced fibrin deposition and intravascular thrombosis in hDAF transgenic pig hearts perfused with tirofiban.
    Brandl U; Jöckle H; Erhardt M; Michel S; Burdorf L; Brenner P; Bittmann I; Rössle M; Mordstein V; Hammer C; Thein E; Reichart B; Schmoeckel M
    Transplantation; 2007 Dec; 84(12):1667-76. PubMed ID: 18165780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement activation, its consequences, and blockade by gene transfer.
    Carrington CA; Richards AC; van den Bogaerde J; Tucker AW; White DJ
    World J Surg; 1997; 21(9):907-12. PubMed ID: 9361503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Porcine islets of langerhans isolated from normal and hDAF transgenic pigs elicit the same acute inflammatory reaction during exposure to human blood; inhibition of the response with soluble complement receptor 1 and heparin.
    Bennet W; Sundberg B; Song Z; Elgue G; Wennberg L; Richards A; White DJ; Larsson R; Nilsson B; Groth C; Korsgren O
    Transplant Proc; 2000 Aug; 32(5):1065. PubMed ID: 10936357
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.